What is bemotrizinol and why is the FDA proposing it?

Bemotrizinol (BEMT) is a UV-absorbing chemical compound offering stable, broad-spectrum sun protection. The FDA is proposing its approval to give Americans access to advanced sunscreen options available globally.

When will bemotrizinol sunscreen be available in the US?

Following a public comment period and final approval, the FDA expects sunscreens with bemotrizinol to be available in the US by summer or fall 2026.

Is the new FDA-proposed sunscreen ingredient safe for children?

Yes, the FDA notes that bemotrizinol has low absorption, rarely causes irritation, and is considered safe for use on children as young as six months old.

Home / Health / FDA Proposes Catch-Up for US Sunscreen Standards

FDA Proposes Catch-Up for US Sunscreen Standards

12 Dec

•

Summary

FDA proposes allowing bemotrizinol, a popular global sunscreen ingredient.
Bemotrizinol offers stable, longer-lasting protection against UV rays.
New sunscreen ingredient could be available by summer or fall 2026.

FDA Proposes Catch-Up for US Sunscreen Standards

The U.S. Food and Drug Administration has taken a significant step towards modernizing sunscreen regulations by proposing the approval of bemotrizinol, a chemical compound widely utilized in sunscreens across other countries for decades. This proposed inclusion aims to offer Americans access to more advanced and effective sun protection.

Bemotrizinol, also known as BEMT, is a broad-spectrum ingredient that absorbs both UVA and UVB rays, providing stable and enduring protection. Its photostability means it breaks down more slowly under sunlight, and it is gentle enough for sensitive skin, including infants as young as six months old.

This proposal follows a public comment period, after which the FDA will issue a final order if safety is confirmed. The agency anticipates that sunscreens featuring bemotrizinol could become available in the United States by summer or fall of 2026, aligning the nation's offerings with international standards.